Search
Virginia Kaklamani, MD, Medicine, Hematology & Oncology, UT Health San Antonio Mays Cancer Center, was interviewed for this news segment about new recommendations for women receiving mammograms. Watch Now
Virginia Kaklamani, MD, Medicine, Hematology & Oncology, UT Health San Antonio Mays Cancer Center, was interviewed for this news segment about new recommendations for women receiving mammograms. Watch Now
Although Lily Espinoza looks forward to her May 21 graduation from the Graduate School of Biomedical Sciences and earning her PhD, she also knows her work will not end there. And not just because there is still research to wrap up, or because she will soon begin her post-doctorate fellowship, but because, for Espinoza, learning is a lifelong pursuit.
Whether you’re going through a tough time or you’re just looking to improve your overall mental health, these tips can be helpful. Click here to learn how to reduce high blood pressure in this article featured in the San Antonio Express-News’ San Antonio Life: Wellness section. The article is part of a wellness series developed […]
Christopher Zhu, a medical student at the Long School of Medicine, was mentioned in this story. Read Now
Lisa Cleveland, PhD, APRN, CPNP-PC, IBCLC, FAAN , School of Nursing, was interviewed for this news segment. Watch Now
May 26 is the new deadline for leaders to apply for Along the Leader’s Path and the Accelerated Management Program. Both programs start in July. Along the Leader’s Path (ALP): Leaders hired or promoted in the last two years are encouraged to enroll in this program. Accelerated Management Program (AMP): For leaders who have completed […]
UT Health San Antonio President William L. Henrich, MD, MACP, was quoted in this article. Read Now
Glioblastoma-impacted mice lived longer when treated with combination of molecule drug and chemotherapy agent Glioblastoma (GBM), a highly devastating brain tumor, has long posed challenges as effective treatments have remained elusive. Despite responding initially to treatment, GBM patients often experience therapy resistance leading to low long-term survival rates, with only 7.2% of patients…
Glioblastoma-impacted mice lived longer when treated with combination of molecule drug and chemotherapy agent Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (May 17, 2023) — Glioblastoma (GBM), a highly devastating brain tumor, has long posed challenges as effective treatments have remained elusive. Despite responding initially to treatment, GBM patients often experience…